Chemical Structure : LXR-623
CAS No.: 875787-07-8
Catalog No.: PC-42687Not For Human Use, Lab Use Only.
LXR-623 (WAY 252623) is a clinically viable, highly brain-penetrant LXRα-partial/LXRβ-full agonist with binding Ki of 33 nM/248 nM, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
25 mg | $198 | In stock | |
100 mg | $488 | In stock | |
200 mg | Get quote | ||
1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
LXR-623 (WAY 252623) is a clinically viable, highly brain-penetrant LXRα-partial/LXRβ-full agonist with binding Ki of 33 nM/248 nM, respectively.
LXR-623 selectively kills GBM cells in an LXRβ- and cholesterol-dependent fashion, causing tumor regression and prolonged survival in mouse models.
M.Wt | 422.7784 | |
Formula | C21H12ClF5N2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: ≥ 47 mg/mL |
|
Chemical Name/SMILES |
2H-Indazole, 2-[(2-chloro-4-fluorophenyl)methyl]-3-(4-fluorophenyl)-7-(trifluoromethyl)- |
1. Wrobel J, et al. J Med Chem. 2008 Nov 27;51(22):7161-8.
2. DiBlasio-Smith EA, et al. J Transl Med. 2008 Oct 16;6:59.
3. Villa GR, et al. Cancer Cell. 2016 Nov 14;30(5):683-693.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright